NCT06961708View on ClinicalTrials.gov

A Study of Fosmanogepix in Healthy Adult Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 14, 2025

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions
Healthy
Interventions
DRUG

Oral Fosmanogepix

Oral Tablet

DRUG

IV Fosmanogepix

IV infusion

DRUG

IV placebo

Matching IV placebo

DRUG

oral placebo

Matching oral placebo

Trial Locations (1)

200237

Shanghai Xuhui Central Hospital, Longchuan North Road, Shanghai

Sponsors
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Basilea Pharmaceutica

INDUSTRY

NCT06961708 - A Study of Fosmanogepix in Healthy Adult Chinese Subjects | Biotech Hunter | Biotech Hunter